Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - Priority Announcement: Global Health Research

University of Calgary

$100,000.00

Defining the role of monocytes in protective immunity against healing and non-healing Leishmaniasis: implications for treatment and vaccination against phagosomal pathogens.

FY 2023-24

Summary
The objective of this grant is to gain a better understanding of the mechanisms of infected cell activation in settings of pre-existing T helper 1 (Th1)/Cell-mediated immunity (prior infection, vaccination) against phagosomal infections. Specifically the infection, manipulation, and activation of host monocytes following challenge infection with non-healing strains or clinical isolates of the protozoan parasite Leishmania. The new knowledge obtained by understanding these mechanisms should inform the downstream development of intervention strategies which, instead of targeting a specific pathogen (i.e. anti-microbials against specific bacteria, parasites or fungi), target a shared infectious process. These broad spectrum immuno-therapeutic approaches to treatment and prevention are likely to be successful against diverse pathogens and help alleviate the growing problem of antimicrobial resistance and long-term drug-treatment regimes. Central Hypothesis: Non-healing strains and some clinical isolates of the Leishmania parasite evade pre-existing Th1 immunity via manipulation of TNF superfamily ligands on monocytes during a 'second stage' of parasite clearance. AIM 1: In settings of pre-existing Th1 anti-Leishmania immunity (healed primary infections, vaccination), CD4 Th1 effector cell (Th1EFF)-mediated monocyte licensing and de novo activation of naïve recent thymic emigrants (RTEs) is required to facilitate a 'second stage' of parasite killing and complete control of challenge infection. AIM 2: Certain clinical isolates, or species of Leishmania associated with non-healing infections, escape 'second stage' control via manipulation of infected CCR2+ monocytes and monocyte derived cells. AIM 3: Evasion of 'second stage' control occurs via manipulation of TNF superfamily ligands on monocytes resulting in failed monocyte licencing and inefficient activation of recent thymic immigrants.
Program
Project Grant - Priority Announcement: Global Health Research
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
495111
Name
Peters Nathan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Defining the role of monocytes in protective immunity against healing and non-healing Leishmaniasis: implications for treatment and vaccination against phagosomal pathogens.
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - Priority Announcement: Global Health Research
Keyworddelim
Clinical Isolates; Intracellular Pathogens; Leishmania; Monocytes; Non-Healing Disease; Phagosomal Infections; T Cells; Tnfr Superfamily; Vaccination
Abstract
The objective of this grant is to gain a better understanding of the mechanisms of infected cell activation in settings of pre-existing T helper 1 (Th1)/Cell-mediated immunity (prior infection, vaccination) against phagosomal infections. Specifically the infection, manipulation, and activation of host monocytes following challenge infection with non-healing strains or clinical isolates of the protozoan parasite Leishmania. The new knowledge obtained by understanding these mechanisms should inform the downstream development of intervention strategies which, instead of targeting a specific pathogen (i.e. anti-microbials against specific bacteria, parasites or fungi), target a shared infectious process. These broad spectrum immuno-therapeutic approaches to treatment and prevention are likely to be successful against diverse pathogens and help alleviate the growing problem of antimicrobial resistance and long-term drug-treatment regimes. Central Hypothesis: Non-healing strains and some clinical isolates of the Leishmania parasite evade pre-existing Th1 immunity via manipulation of TNF superfamily ligands on monocytes during a 'second stage' of parasite clearance. AIM 1: In settings of pre-existing Th1 anti-Leishmania immunity (healed primary infections, vaccination), CD4 Th1 effector cell (Th1EFF)-mediated monocyte licensing and de novo activation of naïve recent thymic emigrants (RTEs) is required to facilitate a 'second stage' of parasite killing and complete control of challenge infection. AIM 2: Certain clinical isolates, or species of Leishmania associated with non-healing infections, escape 'second stage' control via manipulation of infected CCR2+ monocytes and monocyte derived cells. AIM 3: Evasion of 'second stage' control occurs via manipulation of TNF superfamily ligands on monocytes resulting in failed monocyte licencing and inefficient activation of recent thymic immigrants.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Peters, Nathan
Approvedterm
1 an 0 mois
Cihrcontribution2
CRPPHE~ $100,000~ $0~
University of Calgary - $100,000 Grant (2023-24) | Canada Spends